Flint Capital

Flint Capital is a Boston-based venture firm with a transatlantic thesis spanning the US, Europe, and Israel, focused on B2B software, fintech, cybersecurity, and digital health. The flintcap.com website and the firm’s public profile indicate active digital health investing, with portfolio companies in mental health, healthcare operations, and patient-facing software. For healthcare AI founders, Flint is a credible generalist with real digital health exposure rather than a healthcare specialist; the firm is comfortable with software-heavy healthcare businesses but is unlikely to lead pure biotech or medtech rounds. Plausible check sizes run 1M to 5M at Series A, with capacity to follow on. The firm leads or co-leads. Founders building AI-driven mental health, clinical workflow automation, healthcare operations software, patient engagement platforms, or healthcare-adjacent B2B SaaS should approach. Founders building therapeutics, regulated medical devices, or research-stage biology should look at specialist life sciences funds; Flint’s network and value-add are oriented toward software scaling, not FDA strategy. Entry path is LinkedIn direct outreach to partners (the firm has identifiable partners on both sides of the Atlantic), or warm introductions through Boston, New York, or Tel Aviv founder networks. The firm reads inbound and responds to substantive pitches. Diligence will be sharp on B2B SaaS metrics with a layer of healthcare market diligence focused on payer dynamics and adoption motion. Expect a thoughtful, pace-appropriate process, and bring evidence of clinical or operational outcomes alongside software metrics; Flint will appreciate both.